Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasm Metastasis 9Colorectal Neoplasms 7Rectal Neoplasms 5Colorectal Cancer Metastatic 5Ovarian Neoplasms 4Neoplasms 4Lung Neoplasms 3Colonic Neoplasms 3Uveal Melanoma 2Melanoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Somatostatinoma 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neurofibromatosis 2 1Myeloproliferative Disorders 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Macular Degeneration 1

Interventions

Pemetrexed 3Carboplatin 3selpercatinib 2pralsetinib 2pembrolizumab 2sotorasib 1sitravatinib 1patritumab 1osimertinib 1demcizumab 1cobimetinib 1atezolizumab 1aflibercept 1Tyrosine Kinase Inhibitors 1Paclitaxel 1Nivolumab 1Ipilimumab 1Gemcitabine 1Erlotinib Hydrochloride 1Dasatinib 1Cisplatin 1Bevacizumab 1Afatinib 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lung Diseases × aflibercept × Clear all
NCT00284141 2012-12-10

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Sanofi

Phase 2 Completed
98 enrolled 14 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡